Q2 2025 Holdings
Filed 2025-08-12 | 21 holdings | $405.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $43.1M | 428,600 | 10.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $42.7M | 77,430 | 10.5% |
| Natera Inc(NTRA) | COM | 632307104 | $39.9M | 235,964 | 9.8% |
| Illumina Inc(ILMN) | COM | 452327109 | $32.8M | 343,361 | 8.1% |
| Icon PLC(ICLR) | SHS | G4705A100 | $29.5M | 202,790 | 7.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $27.3M | 217,200 | 6.7% |
| Dexcom Inc(DXCM) | COM | 252131107 | $23.9M | 273,821 | 5.9% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $22.8M | 627,600 | 5.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $20.2M | 366,812 | 5.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $19.0M | 60,888 | 4.7% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $17.2M | 299,089 | 4.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $15.0M | 46,086 | 3.7% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $12.1M | 226,400 | 3.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $11.9M | 223,750 | 2.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $11.2M | 259,300 | 2.8% |
| Guardant Health Inc(GH) | COM | 40131M109 | $11.0M | 212,000 | 2.7% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $11.0M | 330,830 | 2.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $9.5M | 269,400 | 2.4% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $2.4M | 4,390 | 0.6% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $1.5M | 46,300 | 0.4% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $1.2M | 240,500 | 0.3% |